GDRX Earnings

GDRX reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 192.06M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.09 by 0%. The stock experienced a -18.78% price change on the earnings day and a -15.51% change over the next five days, reflecting market reactions to the results.

Following GDRX's earnings announcement on 2026-02-25, the stock price moved by -18.78% on the day of the release. Over the subsequent five days, it saw a -15.51% change. Historically, GDRX's stock price tends to shift by an average of 7.96% in the 10 days leading up to earnings and 1.08% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate GDRX's annual revenue to reach 193.75M, while the EPS is projected at 0.03. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GDRX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GDRX's stock price typically moves by 7.96% in the 10 days before its earnings and 1.08% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.03 and revenue of 193.75M.

The earnings call reveals strong growth prospects, including a 35% YoY increase in Manufacturer Solutions revenue and strategic investments in e-commerce and subscriptions, despite a slight revenue decline due to timing. Positive trends in Pharma Direct and increasing web traffic, alongside durable partnerships, indicate optimism. However, margin pressures and lower take rates are concerns, but the overall sentiment remains positive due to the company's strategic direction and market expansion efforts. The market cap suggests moderate stock volatility, aligning with a positive prediction.